Century Therapeutics (IPSC) EBT Growth (1y) (2021 - 2026)
Century Therapeutics (IPSC) EBT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,140.26% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 71.54% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.15% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 116.44% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Century Therapeutics | 406.30 Mn | 271.49 Mn | - | -218.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -218.75% |
| Dec 31, 2025 | 72.16% |
| Sep 30, 2025 | -10.21% |
| Jun 30, 2025 | -4.35% |
| Mar 31, 2025 | 372.83% |
| Dec 31, 2024 | 14.83% |
| Sep 30, 2024 | 2.78% |
| Jun 30, 2024 | 3.57% |
| Mar 31, 2024 | 6.64% |
| Dec 31, 2023 | -27.23% |
| Sep 30, 2023 | -4.57% |
| Jun 30, 2023 | -4.43% |
| Mar 31, 2023 | 19.84% |
| Dec 31, 2022 | -12.43% |
| Sep 30, 2022 | -18.13% |
| Jun 30, 2022 | -33.07% |
| Mar 31, 2022 | -104.37% |
| Dec 31, 2021 | -95.26% |
| Sep 30, 2021 | -96.84% |
| Jun 30, 2021 | -49.30% |